Abstract: A multi-layer coating system includes: a first coating layer formed from a first coating composition including: a film forming resin; and a fluorescent and/or phosphorescent pigment that: (1) emits radiation at an emission wavelength in the range of from 400-1200 nanometers when excited by ultraviolet and/or visible radiation corresponding to an excitation wavelength of the fluorescent and/or phosphorescent pigment; and/or (2) emits radiation at an emission wavelength in the range of from 600-2500 nanometers when excited by visible and/or near infrared radiation corresponding to an excitation wavelength of the fluorescent and/or phosphorescent pigment; and a second coating layer disposed over at least a portion of the first coating layer, which is formed from a second coating composition including: a film forming resin; and a pigment that blocks radiation corresponding to the excitation and/or emission wavelength of the fluorescent and/or phosphorescent pigment in the first coating layer.

Abstract: The invention provides a compound of formula (0): or a pharmaceutically acceptable salt, N-oxide or tautomer thereof; wherein: n is 1 or 2; X is CH or N; Y is selected from CH and C—F; Z is selected from C—Rz and N; R1 is selected from: -(Alk1)t-Cyc1; wherein t is 0 or 1; Optionally substituted C1-6 acyclic hydrocarbon groups R2 is selected from hydrogen; halogen; and C1-8 hydrocarbon groups optionally substituted with one or more fluorine atoms; R3 is hydrogen or a group L1-R7; R4 is selected from hydrogen; methoxy; and optionally substituted C1-3 alkyl; and R4a is selected from hydrogen and a C1-3 alkyl group; wherein Rz, Alk1, Cyc1, L1 and R7 are defined herein; provided that the compound is other than 6-benzyl-3-{2-[(2-methylpyrimidin-4-yl)amino]pyridin-4-yl}-7,8-dihydro-1,6-naphthyridin-5(6H)-one and 3-{2-[(2-methylpyrimidin-4-yl)amino]pyridin-4-yl}-7,8-dihydro-1,6-naphthyridin-5(6H)-one and salts and tautomers thereof.

Abstract: The invention relates to novel compounds having the general formula Ic wherein R1, R2, R3, R8, R9, RX, A1, A2, W and n are as described herein, composition including the compounds and methods of using the compounds.

Abstract: The present disclosure is directed to a composite structure comprising at least one reinforced polymer layer comprising a reinforcing material; a layer comprising a metal substrate comprising a surface and a conformal organic coating present on at least a portion of the surface; wherein the layer comprising the metal substrate is in direct contact with the reinforced polymer layer, and the reinforcing material is more noble than the metal substrate. Also disclosed is a method of making a composite structure, a surfacing film, and a test method for evaluating the galvanic corrosion resistance of a metal substrate test piece.

Abstract: The present invention relates to a substrate having (a) a first material applied to at least a portion of the substrate, and (b) a coating layer deposited from a powder coating composition including a film-forming resin, and optionally a crosslinker that is reactive with the film-forming resin, in direct contact with at least a portion of the substrate to which the first material has been applied. The first material is (i) a catalyst that catalyzes cure of the powder coating composition, (ii) a component reactive with the film-forming resin and/or the crosslinker of the powder coating composition, and/or (iii) a rheology modifier.

Abstract: The present invention is directed to a coating composition comprising a film-forming binder; and a corrosion inhibitor comprising at least one of morpholines, monosulfides, and/or piperazines. The present invention is also directed to coatings, coated metal substrates, multi-layered coated metal substrates, and methods of coating substrates.

Abstract: The present disclosure is directed to a coating composition comprising a film-forming binder, and a corrosion inhibitor comprising a polysulfide corrosion inhibitor, wherein the polysulfide corrosion inhibitor has a passive window value measured as a solution over a substrate greater than the passive window value of a solution without the corrosion inhibitor tested over the same substrate, as measured according to the PASSIVE WINDOW TEST METHOD, and the poly sulfide corrosion inhibitor has a polarization resistance (Rp) measured as a solution over a substrate greater than the polarization resistance (Rp) of a solution without the corrosion inhibitor tested over the same substrate, as measured according to the LINEAR POLARIZATION RESISTANCE TEST METHOD.

Abstract: The present invention is directed to a coated metal substrate comprising a metal substrate; and a coating applied over at least a portion of the metal substrate, wherein the coating comprises a film-forming binder; magnesium oxide; an aluminum compound and/or iron compound; and aluminum particles. The present invention also provides a curable film-forming coating composition comprising a film-forming binder; magnesium oxide; an aluminum and/or iron compound; and aluminum particles. Also disclosed are methods of coating a substrate.

Abstract: The present disclosure is directed to a coated metal substrate comprising a metal substrate; a coating applied over at least a portion of the metal substrate, wherein the coating comprises a film-forming binder; magnesium oxide; and an aluminum compound and/or iron compound; wherein the coating has a dry film thickness of at least 10 microns, and the magnesium oxide and the aluminum and/or iron compound are present in a weight ratio of 1:1 to 240:1. The present disclosure is also directed to a curable film film-forming coating composition a film-forming binder; magnesium oxide; and an aluminum compound and/or iron compound, wherein the magnesium oxide and the aluminum and/or iron compound are present in a weight ratio of 1:1 to 240:1. Also disclosed are methods of coating a substrate.

Abstract: The invention provides a compound of formula (0): or a pharmaceutically acceptable salt, N-oxide or tautomer thereof; wherein: n is 1 or 2; X is CH or N; Y is selected from CH and C—F; Z is selected from C—Rz and N; R1 is selected from: -(Alk1)t-Cyc1; wherein t is 0 or 1; Optionally substituted C1-6 acyclic hydrocarbon groups R2 is selected from hydrogen; halogen; and C1-3 hydrocarbon groups optionally substituted with one or more fluorine atoms; R3 is hydrogen or a group L1-R7; R4 is selected from hydrogen; methoxy; and optionally substituted C1-3 alkyl; and R4a is selected from hydrogen and a C1-3 alkyl group; wherein Rz, Alk1, Cyc1, L1 and R7 are defined herein; provided that the compound is other than 6-benzyl-3-{2-[(2-methylpyrimidin-4-yl)amino]pyridin-4-yl}-7,8-dihydro-1,6-naphthyridin-5(6H)-one and 3-{2-[(2-methylpyrimidin-4-yl)amino]pyridin-4-yl}-7,8-dihydro-1,6-naphthyridin-5(6H)-one and salts and tautomers thereof.

Abstract: The present disclosure explains a system and method for determining a spatial orientation of a weapon in an augmented reality training environment. Fiducial markers are mounted on the weapon and two cameras are mounted on a user's head to capture spatial coordinates of the plurality of fiducial markers. The spatial coordinates of fiducial markers are processed to determine the spatial orientation of the weapon and a simulated discharging of the weapon. Augmented reality imagery is generated based on the spatial orientation and the detected movement. The augmented reality imagery corresponding to the spatial orientation and discharging of the weapon is rendered for the user with the head-mounted display.

Abstract: Some fluid coupling devices described herein are configured for use in fluid systems for purposes of providing a sterile connection for drug delivery. In some embodiments, the fluid coupling devices can be implemented as multi-use, sterile fluid coupling devices that are configured to reduce the likelihood of fluid spillage when being disconnected.

Abstract: Some fluid coupling devices described herein are configured for use in fluid systems for purposes of providing a sterile connection for drug delivery. In some embodiments, the fluid coupling devices can be implemented as multi-use, sterile fluid coupling devices that are configured to reduce the likelihood of fluid spillage when being disconnected.

Abstract: A self-encrypting drive (SED) comprises an SED controller and a nonvolatile storage medium (NVSM) responsive to the SED controller. The SED controller enables the SED to perform operations comprising: (a) receiving an encrypted media encryption key (eMEK) for a client; (b) decrypting the eMEK into an unencrypted media encryption key (MEK); (c) receiving a write request from the client, wherein the write request includes data to be stored and a key tag value associated with the MEK; (d) using the key tag value to select the MEK for the write request; (e) using the MEK for the write request to encrypt the data from the client; and (f) storing the encrypted data in a region of the NVSM allocated to the client. Other embodiments are described and claimed.

Abstract: The invention provides a compound of formula (0): or a pharmaceutically acceptable salt, N-oxide or tautomer thereof; wherein: n is 1 or 2; X is CH or N; Y is selected from CH and C—F; Z is selected from C—Rz and N; R1 is selected from: -(Alk1)t-Cyc1; wherein t is 0 or 1; Optionally substituted C1-6 acyclic hydrocarbon groups R2 is selected from hydrogen; halogen; and C1-3 hydrocarbon groups optionally substituted with one or more fluorine atoms; R3 is hydrogen or a group L1-R7; R4 is selected from hydrogen; methoxy; and optionally substituted C1-3 alkyl; and R4a is selected from hydrogen and a C1-3 alkyl group; wherein Rz, Alk1, Cyc1, L1 and R7 are defined herein; provided that the compound is other than 6-benzyl-3-{2-[(2-methylpyrimidin-4-yl)amino]pyridin-4-yl}-7,8-dihydro-1,6-naphthyridin-5(6H)-one and 3-{2-[(2-methylpyrimidin-4-yl)amino]pyridin-4-yl}-7,8-dihydro-1,6-naphthyridin-5(6H)-one and salts and tautomers thereof.

Abstract: In one aspect the invention is arranged to provide a hair treatment apparatus adapted to reduce the temperature of hair. This apparatus includes at least one thermal energy storage core arranged to draw heat out of hair wherein said at least one thermal energy storage core is arranged to cool hair to a temperature below 0° Celsius.

Abstract: Systems, methods, and computer-readable storage devices are disclosed for improved concurrency of users of a shared virtual environment.